ELEDON PHARMACEUTICALS
Eledon Pharmaceuticals, Inc. is a clinical-stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease.
ELEDON PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2004-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.eledon.com
Total Employee:
11+
Status:
Active
Contact:
+1 949-238-8090
Email Addresses:
[email protected]
Total Funding:
232.76 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS Contact Form 7 GoDaddy DNS COVID-19
Similar Organizations
Rafael Pharmaceuticals
Rafael Pharmaceuticals is clinical-stage, metabolic oncology therapeutics company.
Riparian Pharmaceuticals
Riparian Pharmaceuticals is an early stage biotechnology company.
Relief Therapeutics
Relief Therapeutics is a clinical stage biotechnology company.
Rain Therapeutics
Rain Therapeutics is a operator of a clinical stage biotechnology company.
Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Novelix Pharmaceuticals
Novelix Pharmaceuticals, Inc. (Novelix), is a private, La Jolla based, biotechnology company committed to developing innovative,
VBL Therapeutics
VBL Therapeutics is a clinical-stage platform company developing targeted therapies for immune-inflammatory diseases.
Verrica Pharmaceuticals
Verrica Pharmaceuticals is an innovative clinical-stage medical dermatology company.
Virometix
Virometix is a privately held biotechnology company developing
Magpie Pharmaceuticals
Magpie Pharmaceuticals is a biotechnology company.
Mitochon Pharmaceuticals
Mitochon Pharmaceuticals is a start-up biotech company.
Mimetogen Pharmaceuticals
Mimetogen Pharmaceuticals is a clinical-stage ophthalmology drug development company.
JivanaBiotechnology
Jivana Biotechnology is a preclinical-stage biotechnology company
Metera Pharmaceuticals
Metera Pharmaceuticals is a preclinical stage biotechnology company.
Medicenna Therapeutics
Medicenna is a clinical stage, privately held, immuno-oncology company.
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.
Asieris Pharmaceuticals
Asieris Pharmaceuticals is a Chinese biotech company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Enterin
Philadelphia-based biotechnology company .
Escient Pharmaceuticals
Escient Pharmaceuticals is a privately held biotechnology company.
Ergon Pharmaceuticals
Ergon Pharmaceuticals is a small translational preclinical-stage biotechnology firm
BeiGene
BeiGene is a global oncology company.
Theseus Pharmaceuticals
Theseus Pharmaceuticals is a technology-based company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Specialized Pharmaceuticalss
Specialized Pharmaceuticals is a company focused on Biotechnology.
Seven Bridges
Seven Bridges is the leading biomedical data science company.
Salarius Pharmaceuticals
Salarius Pharmaceuticals is an oncology based biotechnology company.
Disc Medicine
Disc Medicine is a hematology company
Chance Pharmaceuticals
Chance Pharmaceuticals is a clinical-stage biotechnology company focusing on discovering.
Hua Medicine
Hua Medicine is a clinical-stage, innovative drug development company in China.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a drugmaker company.
Giiant Pharma
Giiant Pharma is a preclinical-stage biotech company.
GemPharmatech
GemPharmatech is a biotechnology firm.
OSE Immunotherapeutics
OSE Immunotherapeutics is a clinical-stage biotechnology company focused on developing.
Outplay Inc.
Outplay, Inc. is a science-driven, biotechnology company.
Oxeia Biopharmaceuticals
Oxeia Biopharmaceuticals is a clinical stage biotech company.
Oramed Pharmaceuticals
Oramed Pharmaceuticals develops proprietary Protein Oral Delivery technology for the delivery of drugs.
Organogenesis
Organogenesis Inc. is a regenerative medicine company.
Ortho Regenerative Technologies Inc.
Ortho Regenerative Technologies Inc. is an orthopedic biotechnology company
Xenon Pharmaceuticals
Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.
ZSX Medical
ZSX Medical, LLC, is a pre-clinical stage medical device company.
Cardurion Pharmaceuticals
Cardurion is a Boston-based cardiovascular biotechnology company
Cyagen Biosciences
Cyagen Biosciences is an emerging and innovative biotechnology company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Cantabio Pharmaceuticals
Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Cloudbreak Therapeutics
Cloudbreak Therapeutics is a clinical stage biotechnology company
Panacea Biotec
Panacea Biotec is an Innovation driven Biotechnology company.
Pieris Pharmaceuticals
Pieris Pharmaceuticals is a clinical-stage biotechnology company applying its proprietary.
PetLife Pharmaceuticals Inc
Investment opportunity in the Private Placement, Petlife Pharmaceuticals, Inc. is a publicly traded company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-09-14 | Anelixis Therapeutics | Anelixis Therapeutics acquired by Eledon Pharmaceuticals | N/A |
| 2017-05-10 | Otic Pharma | Otic Pharma acquired by Eledon Pharmaceuticals | N/A |
Investors List
OrbiMed
OrbiMed investment in Post-IPO Equity - Eledon Pharmaceuticals
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Post-IPO Equity - Eledon Pharmaceuticals
Woodline Partners
Woodline Partners investment in Post-IPO Equity - Eledon Pharmaceuticals
BVF Partners
BVF Partners investment in Post-IPO Equity - Eledon Pharmaceuticals
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Eledon Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Equity - Eledon Pharmaceuticals
Logos Capital
Logos Capital investment in Post-IPO Equity - Eledon Pharmaceuticals
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Eledon Pharmaceuticals
Adage Capital Management
Adage Capital Management investment in Post-IPO Equity - Eledon Pharmaceuticals
Ridgeback Capital
Ridgeback Capital investment in Post-IPO Equity - Eledon Pharmaceuticals
Official Site Inspections
http://www.eledon.com Semrush global rank: 6.64 M Semrush visits lastest month: 902
- Host name: 142.7.197.35.bc.googleusercontent.com
- IP address: 35.197.7.142
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Eledon Pharmaceuticals"
Leadership - Eledon Pharmaceuticals, Inc.
Dr. Gros has served as Chief Executive Officer and a member of the Board of Directors of Eledon Pharmaceuticals, Inc. (formerly Novus Therapeutics, Inc.) since September 2020. ... Dr. …See details»
Team - Eledon Pharmaceuticals, Inc.
About Eledon Pharmaceuticals is a clinical stage biotechnology company using its immunology expertise to develop therapies to protect transplanted organs and reduce the risk of organ …See details»
Eledon Pharmaceuticals - Crunchbase Company Profile & Funding
Eledon Pharmaceuticals is a clinical-stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular …See details»
SEC Filing | Eledon Pharmaceuticals, Inc.
Apr 26, 2024 At MyoKardia she built and led a world class development organization culminating in the company’s $13.1 billion acquisition by Bristol Myers Squibb in November 2020. ... He …See details»
Eledon Pharmaceuticals - The Org
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or …See details»
Org Chart Eledon Pharmaceuticals - The Official Board
Organizational Chart of Eledon Pharmaceuticals. Eledon Pharmaceuticals www.eledon.com. has 16 executives +1 949 238 8090; Add an executive. Eledon Pharmaceuticals (ELDN) News . …See details»
Eledon Pharmaceuticals, Inc. (ELDN) - Yahoo Finance
See the company profile for Eledon Pharmaceuticals, Inc. (ELDN) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Eledon Pharmaceuticals, Inc. (ELDN) Company Profile & Overview
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) …See details»
Committee Composition | Eledon Pharmaceuticals, Inc.
Director Name Audit Committee Compensation Committee Nominating & Corporate Governance Committee Science and Technology Committee; Jan Hillson, MDSee details»
Eledon Pharmaceuticals - Overview, News & Similar companies
Founded in 2020, Eledon Pharmaceuticals is a clinical stage biotechnology company using its expertise in targeting the CD40 Ligand (CD40L, also cal led CD154) pathway to develop …See details»
Overview - Eledon Pharmaceuticals, Inc.
We’re advancing next generation therapies to achieve better outcomes for patients. Overview. Focus; Patient Stories; BESTOW Clinical Trial; In The News; Science. Mechanism of ActionSee details»
Contact IR - Eledon Pharmaceuticals, Inc.
Leave this field blank. Overview; Science; Team; Investors; Culture/Careers; Contact; Copyright © 2024 Eledon Pharmaceuticals, Inc. | All Rights Reserved | Privacy ...See details»
Eledon Pharmaceuticals - Funding, Financials, Valuation & Investors
Eledon Pharmaceuticals is registered under the ticker NASDAQ:ELDN . Eledon Pharmaceuticals is funded by 25 investors. Sphera Global Healthcare Fund and Frazier Life Sciences are the …See details»
Eledon Pharmaceuticals Announces Positive Initial Data from …
Oct 29, 2024 Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company that is developing immune-modulating therapies for the management and treatment of life …See details»
David Hovland, | Management | Eledon Pharmaceuticals, Inc.
Dr. Hovland has served as Chief Regulatory Officer of Eledon since April 2021. In this role, he is responsible for Eledon’s Regulatory, Quality, and Safety functions. ... Before Urovant …See details»
Eledon Pharmaceuticals, Inc. (ELDN) - Yahoo Finance Canada
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) …See details»
Focus - Eledon Pharmaceuticals, Inc.
Eledon is striving to both extend the functional life of transplanted organs and reduce side effects of current immunosuppressive treatments such as kidney toxicity, high blood pressure, and …See details»
Eledon Pharmaceuticals (ELDN) Earnings Date and Reports 2025
Dec 27, 2024 Eledon Pharmaceuticals issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.32, which missed analysts' consensus estimates of -$0.30 by $0.02. …See details»
Culture - Eledon Pharmaceuticals, Inc.
Culture As a small company with large ambitions, we are driven by a high-performance, collaborative, accountable, and entrepreneurial work environment. We support each other and …See details»
David Hovland, PhD - Eledon Pharmaceuticals, Inc.
Dr. Hovland has served as Chief Regulatory Officer of Eledon since April 2021. In this role, he is responsible for Eledon’s Regulatory, Quality, and Safety functions. He has over 20 years of …See details»